Can we skip steroids? new strategy tests monitoring for cancer treatment liver side effects
NCT ID NCT05345847
Summary
This study aims to find out if close monitoring works as well as immediate steroid treatment for liver inflammation caused by cancer immunotherapy drugs. It will enroll 56 cancer patients who develop this specific side effect. Participants will be randomly assigned to either receive early high-dose steroids or be closely monitored with steroids only if needed, to see if the monitoring approach is just as effective while potentially avoiding steroid side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS IMMUNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arthur J.E. Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
Contact
Conditions
Explore the condition pages connected to this study.